NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Down 86.7% in July

NewGenIvf Group Limited (NASDAQ:NIVF) was the target of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totaling 8,932 shares, a decrease of 86.7% from the July 15th total of 67,374 shares. Based on an average daily volume of 245,249 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.2% of the company’s stock are short sold.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Friday, July 24th. Wall Street Zen upgraded shares of NewGenIvf Group to a “hold” rating in a research report on Saturday, July 4th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.

Insider Buying and Selling at NewGenIvf Group

In other NewGenIvf Group news, major shareholder Financial Lp Hrt bought 45,847 shares of the firm’s stock in a transaction on Friday, May 22nd. The shares were purchased at an average price of $2.97 per share, for a total transaction of $136,165.59. Following the transaction, the insider directly owned 37,295 shares in the company, valued at approximately $110,766.15. This trade represents a -536.10% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 31.80% of the company’s stock.

NewGenIvf Group Stock Up 5.0%

NASDAQ NIVF traded up $0.03 during trading hours on Thursday, hitting $0.55. 4,404,586 shares of the company’s stock were exchanged, compared to its average volume of 899,993. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12. The business’s 50 day moving average is $1.38 and its 200-day moving average is $5.20. NewGenIvf Group has a 12-month low of $0.45 and a 12-month high of $513.00.

NewGenIvf Group (NASDAQ:NIVF) last announced its quarterly earnings results on Tuesday, March 31st. The company reported ($861.72) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million during the quarter. Sell-side analysts forecast that NewGenIvf Group will post 14.22 earnings per share for the current fiscal year.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.